Explore critical insights from InMed Pharmaceuticals Inc.'s 8-K report filed on February 10, 2025, detailing stock info, corporate identity, and significant shareholder events.
On February 12, 2025, Inmed Pharmaceuticals Inc. filed an 8-K report revealing essential updates for shareholders regarding its NASDAQ status and more.
Explore InMed Pharmaceuticals Inc.'s latest financial report detailing net losses, revenue growth, and strategic outlook. Key insights for investors on INM's performance.
Explore the latest 8-K filing from InMed Pharmaceuticals Inc. revealing significant updates, financial metrics, and stock information as of December 18, 2024.